Slippers to Reduce Transfer From Floors to Surfaces
Impact of Wearing Slippers on Transfer of Bacteriophage MS2 From Floors in Patient Rooms to Bedding and Surfaces
1 other identifier
interventional
34
1 country
1
Brief Summary
The goal of this study is to determine if wearing slippers will reduce transfer of bacteriophage MS2 from hospital room floors to surfaces in the room and hands of patients. Subjects are randomized to wear slippers versus standard care and cultures are collected at 24 and 48 hours to assess transfer of bacteriophage MS2 from the floor to high-touch surfaces, personal items, bedding, socks or feet, and hands of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2021
CompletedFirst Submitted
Initial submission to the registry
June 12, 2021
CompletedFirst Posted
Study publicly available on registry
June 23, 2021
CompletedJune 25, 2021
June 1, 2021
9 months
June 12, 2021
June 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Contamination of a composite of high-touch surfaces, personal items, socks/feet, bedding, and hands
Cultures for MS2
48 hours
Study Arms (2)
Slippers
EXPERIMENTALPatients wear slippers any time they are out of bed with a goal of avoiding any contact between socks/feet and the floor
Control
NO INTERVENTIONPatients receive standard care with no intervention
Interventions
Eligibility Criteria
You may qualify if:
- Adult patients of 18 years of age or older
- Ambulatory
- Able to demonstrate an understanding of study procedures
You may not qualify if:
- Unable or unwilling to fulfill study requirements.
- Expected length of stay less than 48 hours
- Any patient deemed not suitable for study participation at the discretion of the study investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cleveland VA Medical Center
Cleveland, Ohio, 44106, United States
Related Publications (1)
Haq MF, Alhmidi H, Redmond SN, Cadnum JL, Silva SY, Wilson BM, Donskey CJ. A randomized trial to determine whether wearing slippers reduces transfer of bacteriophage MS2 from floors to patients and surfaces in hospital rooms. Infect Control Hosp Epidemiol. 2023 Apr;44(4):670-673. doi: 10.1017/ice.2021.475. Epub 2022 Aug 23.
PMID: 35997135DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Curtis J Donskey, MD
Cleveland VA Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Lab personnel processing cultures blinded to the study group
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 12, 2021
First Posted
June 23, 2021
Study Start
August 1, 2020
Primary Completion
April 20, 2021
Study Completion
April 20, 2021
Last Updated
June 25, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Available 6/22/21 through 6/22/24
- Access Criteria
- Written request
We will provide de-identified individual participant data to those who provide a request in writing.